Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月

Minutes of the 10th Anniversary Celebration Meeting of the Beijing Pathology Technology Group

Continue reading
06 2 月

Registration Now Open! The 26th Academic Conference of the Chinese Society of Pathology and the 10th Chinese Pathology Annual Meeting

Continue reading
06 2 月

MaxVisionTM /AP Immunohistochemical Staining Procedure

Continue reading
06 2 月

MaiXin P16/Ki-67 Dual Staining Detection Technology Debuts at the High-Tech Fair

Continue reading
06 2 月

Cancer Talk: Does Radiation Cause Cancer?

Continue reading
06 2 月

Warm Congratulations on the Successful Conclusion of the “2017 Henan Province Pathology Technology Seminar and Immunohistochemistry Training Course”

Continue reading
06 2 月

In Memory | A Shining Example in the Medical Field, Deeply Remembering Professor Liu Yanfang!

Continue reading
06 2 月

Seventeenth Issue of “Mai Mai” Pathology Weekly Reading Notes | Immunohistochemical Markers for Diagnosis of Kidney and Urinary Tract Tumors (Part 1)

Continue reading
06 2 月

IHC Master’s Diary: Setting Up Controls

Continue reading
06 2 月

Immunohistochemical Expression of CA IX, GLUT-1, and Pax-8 in Von Hippel-Lindau Syndrome

Continue reading
  • «
  • ‹
  • 41
  • 42
  • 43
  • 44
  • 45
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar